Cargando…
T cell epitope: Friend or Foe? Immunogenicity of biologics in context()
Like vaccines, biologic proteins can be very immunogenic for reasons including route of administration, dose frequency and the underlying antigenicity of the therapeutic protein. Because the impact of immunogenicity can be quite severe, regulatory agencies are developing risk-based guidelines for im...
Autores principales: | Weber, Constanze A., Mehta, Preema J., Ardito, Matt, Moise, Lenny, Martin, Bill, De Groot, Anne S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7103283/ https://www.ncbi.nlm.nih.gov/pubmed/19619593 http://dx.doi.org/10.1016/j.addr.2009.07.001 |
Ejemplares similares
-
A Method for Individualizing the Prediction of Immunogenicity of Protein Vaccines and Biologic Therapeutics: Individualized T Cell Epitope Measure (iTEM)
por: Cohen, Tobias, et al.
Publicado: (2010) -
Immunogenic Consensus Sequence T helper Epitopes for a Pan-Burkholderia Biodefense Vaccine
por: De Groot, Anne S., et al.
Publicado: (2011) -
New Immunoinformatics Tools for Swine: Designing Epitope-Driven Vaccines, Predicting Vaccine Efficacy, and Making Vaccines on Demand
por: Moise, Lenny, et al.
Publicado: (2020) -
ZEB Proteins in Leukemia: Friends, Foes, or Friendly Foes?
por: Soen, Bieke, et al.
Publicado: (2018) -
H7N9 T-cell epitopes that mimic human sequences are less immunogenic and may induce Treg-mediated tolerance
por: Liu, Rui, et al.
Publicado: (2015)